ArticleBMJ (Clinical research ed.)2000

Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

A J Krentz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.